AB — AB Science SA Share Price
- €72.70m
- €82.61m
- €0.97m
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | n/a | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 67.19 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -150.18% | ||
Return on Equity | n/a | ||
Operating Margin | -754.25% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | €m | 1.57 | 1.58 | 1.61 | 0.96 | 0.97 | 1.1 | 1.22 | -10.63% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
AB Science SA, also known as AB Science, is a France-based pharmaceutical company specialized in the research, discovery, development and marketing of protein kinase inhibitors (PKIs). It is engaged in targeted therapies through tyrosine kinase inhibitors for treating diseases with high medical factor in the field of cancer, chronic inflammatory diseases, neurological degenerative disorders and central nervous systems diseases in both human and veterinary medicine. The main focus of the Company is the development of tyrosine kinase inhibitors, for instance Masitinib which is a tyrosine kinase inhibitor used as a veterinary medicine in the treatment of canine mast cell tumors. The Company is present in the United States and Europe. As of December 31, 2013, the Company operated though a subsidiary, AB Science USA LCC, based in the United States.
Directors
- Alain Moussy CHM
- Denis Gicquel DCE
- Laurent Guy CFO
- Patrick Moussy DRC
- Renaud Sassi DRC
- Cecile De Guillebon IND (59)
- Catherine Johnston-Roussillo IND
- Guillemette Latscha IND
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- July 3rd, 2001
- Public Since
- April 21st, 2010
- No. of Employees
- 45
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
Euronext - Paris
- Shares in Issue
- 52,375,019

- Address
- 3 avenue George V, PARIS, 75008
- Web
- https://www.ab-science.com/
- Phone
- +33 147200014
- Auditors
- Audit et Conseil Union
Upcoming Events for AB
Ab Science SA Annual Shareholders Meeting
Similar to AB
Advicenne SA
Euronext - Paris
Aelis Farma SA
Euronext - Paris
Boiron SA
Euronext - Paris
DBV Technologies SA
Euronext - Paris
Elsalys Biotech SA
Euronext - Paris
FAQ
As of Today at 18:03 UTC, shares in AB Science SA are trading at €1.39. This share price information is delayed by 15 minutes.
Shares in AB Science SA last closed at €1.39 and the price had moved by -37.19% over the past 365 days. In terms of relative price strength the AB Science SA share price has underperformed the FTSE Global All Cap Index by -43.16% over the past year.
The overall consensus recommendation for AB Science SA is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreAB Science SA does not currently pay a dividend.
AB Science SA does not currently pay a dividend.
AB Science SA does not currently pay a dividend.
To buy shares in AB Science SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €1.39, shares in AB Science SA had a market capitalisation of €72.70m.
Here are the trading details for AB Science SA:
- Country of listing: France
- Exchange: PAR
- Ticker Symbol: AB
Based on an overall assessment of its quality, value and momentum AB Science SA is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in AB Science SA is €3.40. That is 144.96% above the last closing price of €1.39.
Analysts covering AB Science SA currently have a consensus Earnings Per Share (EPS) forecast of -€0.41 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like AB Science SA. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +27.53%.
As of the last closing price of €1.39, shares in AB Science SA were trading +21.73% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The AB Science SA PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at €1.39.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
AB Science SA's management team is headed by:
- Alain Moussy - CHM
- Denis Gicquel - DCE
- Laurent Guy - CFO
- Patrick Moussy - DRC
- Renaud Sassi - DRC
- Cecile De Guillebon - IND
- Catherine Johnston-Roussillo - IND
- Guillemette Latscha - IND